USNA
USANA Health Sciences, Inc. Consumer Staples - Nutritional Supplements Investor Relations →
USANA Health Sciences, Inc. (USNA) closed at $16.91 as of 2026-03-20, trading 62.5% below its 200-week moving average of $45.04. This places USNA in the extreme value zone. The stock is currently moving closer to the line, down from -61.7% last week. The 14-week RSI sits at 34, indicating neutral momentum.
Trading volume is running at 1.3x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.97 ratio) is neutral — neither side is clearly dominating.
Over the past 1619 weeks of data, USNA has crossed below its 200-week moving average 22 times. On average, these episodes lasted 29 weeks. Historically, investors who bought USNA at the start of these episodes saw an average one-year return of +8.2%.
With a market cap of $312 million, USNA is a small-cap stock. The company generates a free cash flow yield of 11.8%, which is notably high. Return on equity stands at 2.0%. The stock trades at 0.6x book value.
Management has been repurchasing shares, with a 4.8% reduction over three years. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 31.1 years, a hypothetical investment of $100 in USNA would have grown to $2848, compared to $2235 for the S&P 500. That represents an annualized return of 11.4% vs 10.5% for the index — confirming USNA as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been declining at a -55% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: USNA vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After USNA Crosses Below the Line?
Across 22 historical episodes, buying USNA when it crossed below its 200-week moving average produced an average return of +5.1% after 12 months (median +5.0%), compared to +4.6% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +22.2% vs +15.0% for the index.
Each line shows $100 invested at the moment USNA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
USNA has crossed below its 200-week MA 22 times with an average 1-year return of +8.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 1999 | May 1999 | 8 | 23.8% | -36.1% | +651.6% |
| May 1999 | Jun 2002 | 159 | 82.5% | -48.6% | +673.0% |
| May 2007 | Jun 2007 | 1 | 3.4% | -31.5% | -9.0% |
| Jul 2007 | Sep 2007 | 7 | 14.1% | -16.2% | -11.4% |
| Nov 2007 | Nov 2007 | 1 | 0.2% | -11.0% | -15.5% |
| Dec 2007 | Jan 2008 | 7 | 11.7% | -20.4% | -16.0% |
| Feb 2008 | Sep 2008 | 32 | 52.5% | -29.5% | -11.3% |
| Sep 2008 | May 2010 | 86 | 52.2% | -13.3% | -14.8% |
| Feb 2011 | Feb 2011 | 2 | 1.4% | +10.3% | -0.3% |
| Mar 2011 | Mar 2011 | 3 | 2.8% | +13.0% | +1.4% |
| May 2011 | Oct 2011 | 24 | 28.7% | +37.6% | +20.6% |
| Nov 2011 | Jan 2012 | 8 | 7.1% | +41.7% | +9.0% |
| Dec 2012 | Dec 2012 | 2 | 9.5% | +129.3% | N/A |
| Jan 2013 | Feb 2013 | 1 | 1.7% | +72.6% | -2.5% |
| May 2019 | Dec 2019 | 31 | 23.3% | +8.9% | -77.6% |
| Dec 2019 | Jan 2020 | 1 | 2.2% | N/A | -78.1% |
| Jan 2020 | Apr 2020 | 13 | 39.9% | +16.7% | -77.2% |
| Jun 2020 | Jun 2020 | 3 | 14.7% | +31.7% | -78.7% |
| Jul 2020 | Jul 2020 | 1 | 1.1% | +26.7% | -78.8% |
| Aug 2020 | Feb 2021 | 23 | 8.4% | +24.1% | -78.5% |
| Sep 2021 | Sep 2021 | 1 | 0.1% | -33.1% | -81.0% |
| Feb 2022 | Ongoing | 215+ | 62.5% | Ongoing | -80.8% |
| Average | 29 | — | +8.2% | — |
Frequently Asked Questions
Is USNA below its 200-week moving average?
Yes. As of 2026-03-20, USANA Health Sciences, Inc. (USNA) is trading 62.5% below its 200-week moving average of $45.04. The current price is $16.91.
What is USNA's 200-week moving average price?
USANA Health Sciences, Inc.'s 200-week moving average is $45.04 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when USNA drops below its 200-week moving average?
USNA has crossed below its 200-week moving average 22 times in our data. On average, buying at that moment produced a one-year return of +8.2%. These dips have historically been decent entry points. These episodes lasted 29 weeks on average.
Is USNA a good value right now?
Here's what our data says about USNA as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 34. Free cash flow yield is 11.8%. Return on equity is 2.0%. Price-to-book is 0.6x. This is not a buy or sell recommendation — always do your own research.
How does USNA compare to the S&P 500?
Over the past 31.1 years, $100 invested in USNA would have grown to $2848, compared to $2235 for the S&P 500. That's 11.4% annualized vs 10.5% for the index. USNA has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20